GoodRx (NASDAQ: GDRX) revenue
GoodRx reported revenue of $796.9m for fiscal 2025, 0.6% more than in fiscal 2024 ($792.3m). Since fiscal 2019 its revenue has grown by 105.3%, an average growth of 12.7% a year.
GoodRx has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 7 fiscal years on record. The biggest drop was in fiscal 2023, −2.1%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $796.9m | +0.6% | $87.5m | 11.0% |
| 2024 | $792.3m | +5.6% | $65.8m | 8.3% |
| 2023 | $750.3m | −2.1% | −$27.0m | −3.6% |
| 2022 | $766.6m | +2.8% | $1.7m | 0.2% |
| 2021 | $745.4m | +35.4% | $13.4m | 1.8% |
| 2020 | $550.7m | +41.9% | −$275.7m | −50.1% |
| 2019 | $388.2m | — | $139.7m | 36.0% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
GoodRx revenue compared with its sector
By revenue for its latest fiscal year, GoodRx ranks 167th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; GoodRx, 0.6%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 165th | Myriad Genetics | $824.5m | −1.6% |
| 166th | Orthofix Medical | $822.3m | 2.9% |
| 167th | GoodRx | $796.9m | 0.6% |
| 168th | U S Physical Therapy | $781.0m | 16.3% |
| 169th | Collegium Pharmaceutical | $780.6m | 23.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of GoodRx
- How much revenue did GoodRx make in fiscal 2025?
- GoodRx reported revenue of $796.9m for fiscal 2025, compared with $792.3m in fiscal 2024.
- How much has the revenue of GoodRx grown?
- Between fiscal 2019 and fiscal 2025 it went from $388.2m to $796.9m: 105.3% more, an average growth of 12.7% a year.
- What was the best year for revenue at GoodRx?
- Of its last 7 fiscal years, fiscal 2025, with $796.9m.
- Where does GoodRx rank in its sector by revenue?
- It ranks 167th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for GoodRx come from?
- From the annual report (Form 10-K) that GoodRx files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that GoodRx files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on GoodRx: the GoodRx page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.